ArticleJournal of experimental & clinical cancer research : CR2018

miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.

Maria Francesca Santolla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.